204 related articles for article (PubMed ID: 11172955)
1. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
[TBL] [Abstract][Full Text] [Related]
2. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
[TBL] [Abstract][Full Text] [Related]
3. Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Ha CS; Lee MS; McLaughlin P; Tucker SL; Wilder RB; Cox JD; Cabanillas F
Cancer J; 2004; 10(1):49-53. PubMed ID: 15000495
[TBL] [Abstract][Full Text] [Related]
4. Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
Ha CS; Tucker SL; Blanco AI; Wilder RB; McLaughlin P; Cabanillas F; Cox JD
Cancer; 2001 Sep; 92(5):1074-9. PubMed ID: 11571717
[TBL] [Abstract][Full Text] [Related]
5. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
Ha CS; Kong JS; Tucker SL; McLaughlin P; Wilder RB; Hess MA; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):316-20. PubMed ID: 12957240
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
Ha CS; Cabanillas F; Lee MS; Tucker SL; McLaughlin P; Rodriguez MA; Younes A; Romaguera JE; Mesina OM; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):188-93. PubMed ID: 16111588
[TBL] [Abstract][Full Text] [Related]
7. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
9. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
Ha CS; Tucker SL; Blanco AI; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1207-12. PubMed ID: 10613314
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
11. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
[TBL] [Abstract][Full Text] [Related]
12. The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma.
Moos M; Schulz R; Martin S; Benner A; Haas R
Leukemia; 1998 Dec; 12(12):1971-6. PubMed ID: 9844927
[TBL] [Abstract][Full Text] [Related]
13. Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells.
Pichert G; Schmitz SF; Hess U; Cerny T; Cogliatti SB; Betticher D; Stupp R; Schmitter D; Stahel RA; Ghielmini M
Clin Lymphoma; 2001 Mar; 1(4):293-7. PubMed ID: 11707844
[TBL] [Abstract][Full Text] [Related]
14. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
15. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
16. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
[TBL] [Abstract][Full Text] [Related]
17. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
[TBL] [Abstract][Full Text] [Related]
18. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma.
Finke J; Slanina J; Lange W; Dölken G
J Clin Oncol; 1993 Sep; 11(9):1668-73. PubMed ID: 8355034
[TBL] [Abstract][Full Text] [Related]
19. Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Tsimberidou AM; Jiang Y; Ford RJ; Lichtiger B; Medeiros LJ; McLaughlin P; Cabanillas F; Sarris AH
Leuk Lymphoma; 2002 Aug; 43(8):1589-98. PubMed ID: 12400601
[TBL] [Abstract][Full Text] [Related]
20. Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma.
Panjan M; Boltezar L; Novakovic S; Kokovic I; Jezersek Novakovic B
Radiol Oncol; 2023 Dec; 57(4):487-492. PubMed ID: 37439703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
